Lupin Ltd. is a multinational pharmaceutical company based in India. It is primarily involved in the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company's product portfolio includes generic and branded formulations, active pharmaceutical ingredients (APIs), and specialties across various therapeutic areas including cardiovascular, central nervous system, diabetes, respiratory, anti-infective, gastrointestinal, and women's health. Lupin has a notable presence in both emerging markets and established regions such as the United States and Europe. Its commitment to affordable healthcare and innovation is evident through its extensive research and development initiatives, supported by multiple facilities worldwide. As a key player in the global pharmaceutical industry, Lupin Ltd. plays a significant role in advancing public health by providing access to essential medications and investing in drug discovery and biotechnology solutions.